Odile Filhol

Title: Odile Filhol: Innovator in Cancer Treatment

Introduction

Odile Filhol is a prominent inventor based in Claix, France, known for her significant contributions to cancer treatment through innovative drug combinations. With a focus on renal cell carcinoma and prostate cancer, her work has led to the development of novel therapeutic methods that aim to improve patient outcomes.

Latest Patents

Odile Filhol holds 2 patents that showcase her expertise in the field of oncology. Her latest patents include a synthetic lethal drug combination for treating renal cell carcinoma, which involves a unique treatment approach targeting tumors with VHL inactivation. This invention combines a first agent that inhibits protein kinase CK2 and a second agent that inhibits Ataxia Telangiectasia Mutated (ATM) kinase. Additionally, she has developed an in vitro method for diagnosing prostate cancer, which utilizes antibodies directed against CK2-α for diagnosis and prognosis.

Career Highlights

Throughout her career, Odile has worked with esteemed organizations such as the National Institute of Health and Medical Research and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Odile has collaborated with notable colleagues, including Claude Cochet and Sofia Giacosa, who have contributed to her research endeavors and innovations in cancer treatment.

Conclusion

Odile Filhol's innovative work in cancer treatment and diagnosis highlights her dedication to improving healthcare outcomes. Her patents and collaborations reflect her commitment to advancing medical science and providing new solutions for patients battling cancer.